ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,192Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 625

$714K Total Retail Price of All Prescriptions

Rank: 83 out of 625

478 Patients Receiving at Least One Drug in Part D
33%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

63% of this provider’s 478 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 5,070 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 2,338 452 S3 1 4
CYCLOBENZAPRINE HCL 484 43 R 2 65
ZOLPIDEM TARTRATE 450 97 3 13
AMLODIPINE BESYLATE 416 219 4 1
PRAVASTATIN SODIUM 278 137 5 8
FUROSEMIDE 274 153 6 7
OMEPRAZOLE 274 134 6 6
LISINOPRIL 272 108 8 5
SIMVASTATIN 271 138 9 2
BENAZEPRIL HCL 269 120 10 35
PROMETHAZINE HCL 266 66 R 11 84
HYDROCHLOROTHIAZIDE 240 110 12 12
TRAMADOL HCL 239 55 13 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 225 126 14 27
ATENOLOL 223 130 15 22
NEXIUM 221 28 16 21
GABAPENTIN 215 58 17 14
LYRICA 195 0 18 71
METFORMIN HCL 187 74 19 10
MELOXICAM 180 97 20 31
TIZANIDINE HCL 176 26 21 115
METOPROLOL TARTRATE 173 88 22 11
ATORVASTATIN CALCIUM 171 87 23 9
NIFEDIPINE ER 163 104 24 111
AZITHROMYCIN 130 50 25 40
FLUTICASONE PROPIONATE 128 45 26 32
DIOVAN HCT 128 49 26 52
RANITIDINE HCL 126 47 28 25
IBUPROFEN 120 34 29 114
CLOPIDOGREL 116 66 30 30
CLONIDINE HCL 113 50 31 50
GLIPIZIDE 99 59 32 56
WARFARIN SODIUM 93 63 33 20
GLIPIZIDE ER 92 37 34 68
LEVOTHYROXINE SODIUM 91 40 35 3
DIOVAN 83 50 36 28
CITALOPRAM HBR 80 33 37 24
SERTRALINE HCL 79 50 38 26
COLCRYS 78 42 39 117
ATENOLOL-CHLORTHALIDONE 77 35 40 157
ADVAIR DISKUS 77 28 40 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 27 42 116
CYMBALTA 75 0 43 46
VENTOLIN HFA 74 19 44 93
INSULIN SYRINGE 74 51 44 77
PLAVIX 70 37 46 43
PREDNISONE 70 30 46 37
BENAZEPRIL-HYDROCHLOROTHIAZIDE 69 21 48 167
SUBOXONE 69 0 48 191
PROAIR HFA 68 37 50 57
COMBIVENT 66 13 51 126
CARVEDILOL 63 30 52 23
LANSOPRAZOLE 61 20 53 159
LANTUS 59 40 54 54
AMLODIPINE BESYLATE-BENAZEPRIL 57 38 55 48
TAMSULOSIN HCL 57 34 55 36
TRAZODONE HCL 57 0 55 51
SINGULAIR 55 18 58 94
FLUOXETINE HCL 54 28 59 62
CIPROFLOXACIN HCL 51 27 60 60
HUMULIN 70-30 51 42 60 210
LEVOFLOXACIN 50 0 62 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.